Skip to content
StockMarketAgent
Sector pending / HospitalsUpdated 2026-05-10 22:07 UTC

FRA/7RA stock hub

FRA/7RA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/7RAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2B
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/7RAFRA/7RA
—
Loading chart…
In the news

Latest news · FRA/7RA

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.6
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-41.1
P25 n/aP50 n/aP75 n/a
ROIC8.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/7RA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
190
Groups with data
11
Currency
USD
Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
25,000
Employees Change
-500%
Employees Change Percent
-1.96
Enterprise value
EUR 4.3B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Hospitals
Last refreshed
2026-05-10
Market cap
EUR 2B
Price
EUR 20.4
Price currency
EUR
Rev Per Employee
132,896.62x
Sic
8060
Symbol
fra/7RA
Website
https://www.acadiahealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
-48.8%
EV Earnings
-4.48x
EV/EBIT
12.86x
EV/EBITDA
7.96x
EV/FCF
-16.99x
EV/Sales
1.5x
FCF yield
-12.86%
Forward P/E
16.61x
P/B ratio
1.05x
P/S ratio
0.67x
PE Ratio10 Y
67.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
11.67%
EBITDA Margin
17.44%
Gross margin
41.81%
Gross Profit
EUR 1.2B
Gross Profit Growth
6.51%
Gross Profit Growth Q
11.92%
Gross Profit Growth3 Y
7.12%
Gross Profit Growth5 Y
10.04%
Net Income
EUR -960.1M
Net Income Growth Q
-50.98%
Pretax Margin
-31.69%
Profit Margin
-32.84%
Profit Per Employee
EUR -43,643
ROA
4.2
Roa5y
5.25
ROCE
7.78
ROE
-41.05
Roe5y
-2.68
ROIC
8.4
Roic5y
8.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr10y
-8.68%
Cagr1y
-1.92%
Cagr3y
-30.77%
Cagr5y
-17.23%
EPS Growth Q
-49.62
OCF Growth
-60.66%
OCF Growth Q
436.12%
OCF Growth10 Y
-4.25%
OCF Growth3 Y
-19.45%
OCF Growth5 Y
-23.39%
Revenue Growth
6.8x
Revenue Growth Q
7.57x
Revenue Growth3 Y
7.71x
Revenue Growth5 Y
9.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
EUR 0.58
Assets
EUR 4.8B
Cash
EUR 137.4M
Current Assets
EUR 709.9M
Current Liabilities
EUR 415M
Debt
EUR 2.3B
Debt EBITDA
EUR 4.23
Debt Equity
EUR 1.24
Debt FCF
EUR -9.23
Equity
EUR 1.9B
Interest Coverage
2.66
Liabilities
EUR 2.9B
Long Term Assets
EUR 4.1B
Long Term Liabilities
EUR 2.5B
Net Cash
EUR -2.2B
Net Cash By Market Cap
EUR -112
Net Debt EBITDA
EUR 4.31
Net Debt Equity
EUR 1.17
Tangible Book Value
EUR 484.2M
Tangible Book Value Per Share
EUR 5.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.71
Inventory Turnover
337
Net Working Capital
EUR 211.4M
Quick ratio
1.44
Working Capital
EUR 301.7M
Working Capital Turnover
EUR 11.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
1.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
-59.68%
1Y total return
-1.92%
200-day SMA
17.24
3Y total return
-66.83%
50-day SMA
20.93
50-day SMA vs 200-day SMA
50over200
5Y total return
-61.14%
All Time High
85.5
All Time High Change
-76.14%
All Time High Date
2022-09-13
All Time Low
9.65
All Time Low Change
111.4%
All Time Low Date
2026-01-19
ATR
0.52
Ch YTD
65.85
High
20.4
High52
24.2
High52 Date
2025-05-13
High52ch
-15.7%
Low
20.4
Low52
9.65
Low52 Date
2026-01-20
Low52ch
111.4%
Ma50ch
-2.55%
Price vs 200-day SMA
18.3%
RSI
40.01
RSI Monthly
39.02
RSI Weekly
55.62
Sharpe ratio
0.28x
Sortino ratio
0.5
Total Return
1.78%
Tr YTD
65.85
Tr1m
-3.77%
Tr1w
-13.56%
Tr3m
71.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 341.1M
Operating Income Growth
-16.65
Operating Income Growth Q
6.8
Operating Income Growth3 Y
-5.07
Operating Income Growth5 Y
2.27
Operating margin
11.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
82,899,063%
Net Borrowing
273,678,887.5
Shares Insiders
1.66%
Shares Institutions
128.59%
Shares Qo Q
0.46%
Shares Yo Y
-1.78%
Short Ratio
6.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
EUR -279.9M
Average Volume
0x
Bv Per Share
18.71
CAPEX
EUR -410.9M
Ch10y
-59.68
Ch1m
-3.77
Ch1w
-13.56
Ch1y
-1.92
Ch3m
71.43
Ch3y
-66.83
Ch5y
-61.14
Ch6m
17.24
Change
-2.86%
Change From Open
0
Close
21
Days Gap
-2.86
Depreciation Amortization
165,049,867.6
Earnings Date
2026-04-29
EBIT
EUR 341.1M
EBITDA
EUR 509.9M
EPS
EUR -10.62
F Score
5
FCF
EUR -253.1M
FCF EV Yield
-5.89x
Financing CF
276,209,898
Fiscal Year End
December
Founded
2,005
Goodwill
1,103,547,922.3
Income Tax
EUR 24.4M
Investing CF
-375,703,085
Is Primary Listing
0
Last Earnings Date
2026-04-29
Last Report Date
2026-03-31
Ma150
16.74
Ma150ch
21.85%
Ma20
22.54
Ma20ch
-9.49%
Net CF
58,313,783
Open
20.4
P OCF Ratio
12.47
Ppne
2,746,374,237.8
Price Date
2026-05-08
Price EBITDA
EUR 3.86
Ptbv Ratio
4.06
Relative Volume
12.44x
Revenue
2,923,725,542x
SBC By Revenue
0.92x
Share Based Comp
26,875,025
Tax By Revenue
0.83x
Tr6m
17.24%
Volume
0
Z Score
1.07
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/7RA pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/7RA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-1.9%
S&P 500 1Y: n/a
3Y total return
-66.8%
S&P 500 3Y: n/a
5Y total return
-61.1%
S&P 500 5Y: n/a
10Y total return
-59.7%
S&P 500 10Y: n/a
Ownership

Who owns FRA/7RA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+128.6%
Share of float held by funds and institutions
Insider ownership
+1.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
6.3 days to cover
Y/Y dilution
-1.8%
Negative means the company is buying back shares.
Technical

FRA/7RA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
40.0
Neutral momentum band
Price vs 200-day MA
+18.3%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.28
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/7RA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/7RA stock rating?

fra/7RA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/7RA analysis?

The full report lives at /stocks/fra/7RA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/7RA?

The latest report frames fra/7RA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/7RA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.